Current Prices from BRIACELL THERAPEUTICSCS CORP - WARRANT

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	BCTXW	USD	09.06.2025 18:26	0,09 USD	0,07 USD +28,57 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	13,35 %	38,46 %	-9,91 %	-82,00 %	-78,17 %	-88,00 %

Company Profile for BRIACELL THERAPEUTICSCS CORP - WARRANT Share

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Company Data

Name BRIACELL THERAPEUTICSCS CORP - WARRANT

Company BriaCell Therapeutics Corp.

Symbol BCTXW

Website https://briacell.com

Primary Exchange

NASDAQ

ISIN CA10778Y1126

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Dr. William V. Williams M.D.

Country Canada

Currency USD

Employees 0,0 T

Address Bellevue Centre, V7T 2X1 West Vancouver

Ticker Symbols

Name	Symbol
NASDAQ	BCTXW

More Shares

Investors who BRIACELL THERAPEUTICSCS CORP - WARRANT hold also have the following shares in their portfolio:

INVESCO EXCHANGE-TRADED SELF-INDEXED FUND TRUST INVESCO RUSSELL 1000 DYNAMIC MULTIFACTOR ETF ETF

LYXOR ETF MSCI EX EMU CDL ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog